Is Mitotane available in China?

Mitotane is a drug commonly used to treat pheochromocytoma and paraganglioma, as well as benign and malignant chromaffin tumors. Pheochromocytoma and pheochromocytoma are tumors that originate from the adrenal glands or other ganglia. These tumors can secrete too much epinephrine and norepinephrine, causing high blood pressure and other serious symptoms.

Mitotane has not yet been launched in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs abroad. The Turkish version of the original drug is about more than 7,000 yuan, followed by the European version of the original drug, which is about 9,000 yuan. There are also cost-effective generic drugs, mainly Laos and ASEAN generic drugs. The price is about more than 3,000 yuan. The ingredients of the original drugs and generic drugs are the same.

The main mechanism of action of mitotane is to inhibit hormone production by interfering with adrenocortical function. This mechanism of action helps reduce the levels of dopamine, norepinephrine, and epinephrine produced by chromaffin cells in the body, thereby alleviating high blood pressure and other symptoms associated with excessive secretion of these hormones.

Mitotane is usually given to patients in the form of oral tablets, but individual dosage adjustments are required to ensure effective treatment and reduce potential adverse effects. Adrenal function and drug concentrations need to be monitored regularly during treatment to ensure patient safety and treatment effectiveness.

Although mitotane has shown good efficacy in the treatment of pheochromocytoma and pheochromocytoma, it may cause a series of adverse reactions, including nausea, vomiting, diarrhea, rash, fatigue, etc. Therefore, doctors need to carefully weigh the potential benefits and risks when using mitotane to determine the most appropriate treatment regimen.